$2M Direct Offering Priced at $0.28/Share for Jupiter Neurosciences
JUNS sits 49% above its 52-week low of $0.172 on elevated volume (11× avg).
Summary
Jupiter Neurosciences priced a $2.0 million registered direct offering, selling 7.14 million shares at $0.28 per share. This capital infusion is critical for the company, which has recently faced Nasdaq delisting threats, issued 'going concern' warnings, and reported increased cash burn in its latest 10-Q. While highly dilutive, this financing provides essential liquidity for continued operations and to fund potential new initiatives, such as the recently announced licensing of ALA-002. The offering price is slightly above the current market price.
At the time of this announcement, JUNS was trading at $0.26 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $9.3M. The 52-week trading range was $0.17 to $3.33. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Wiseek News.